General Information of Drug Off-Target (DOT) (ID: OTBE0PLF)

DOT Name Paired immunoglobulin-like type 2 receptor alpha (PILRA)
Synonyms Cell surface receptor FDF03; Inhibitory receptor PILR-alpha
Gene Name PILRA
Related Disease
Age-related macular degeneration ( )
Alzheimer disease ( )
Herpes simplex infection ( )
Neovascular age-related macular degeneration ( )
46,XY sex reversal 2 ( )
Charcot-Marie-Tooth disease type 3 ( )
Colitis ( )
Inflammatory bowel disease ( )
UniProt ID
PILRA_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
3WUZ; 3WV0; 4NFB; 5XO2; 5XOF
Pfam ID
PF07686
Sequence
MGRPLLLPLLPLLLPPAFLQPSGSTGSGPSYLYGVTQPKHLSASMGGSVEIPFSFYYPWE
LATAPDVRISWRRGHFHRQSFYSTRPPSIHKDYVNRLFLNWTEGQKSGFLRISNLQKQDQ
SVYFCRVELDTRSSGRQQWQSIEGTKLSITQAVTTTTQRPSSMTTTWRLSSTTTTTGLRV
TQGKRRSDSWHISLETAVGVAVAVTVLGIMILGLICLLRWRRRKGQQRTKATTPAREPFQ
NTEEPYENIRNEGQNTDPKLNPKDDGIVYASLALSSSTSPRAPPSHRPLKSPQNETLYSV
LKA
Function
Paired receptors consist of highly related activating and inhibitory receptors and are widely involved in the regulation of the immune system. PILRA is thought to act as a cellular signaling inhibitory receptor by recruiting cytoplasmic phosphatases like PTPN6/SHP-1 and PTPN11/SHP-2 via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules. Receptor for PIANP; (Microbial infection) Acts as an entry co-receptor for herpes simplex virus 1.
Tissue Specificity
Predominantly detected in hemopoietic tissues and is expressed by monocytes, macrophages, and granulocytes, but not by lymphocytes. Also strongly expressed by dendritic cells (DC); preferentially by CD14+/CD1a- DC derived from CD34+ progenitors. Also expressed by CD11c+ blood and tonsil DC, but not by CD11c- DC precursors.
KEGG Pathway
Virion - Herpesvirus (hsa03266 )
Herpes simplex virus 1 infection (hsa05168 )
Reactome Pathway
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell (R-HSA-198933 )

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Age-related macular degeneration DIS0XS2C Strong Genetic Variation [1]
Alzheimer disease DISF8S70 Strong Genetic Variation [2]
Herpes simplex infection DISL1SAV Strong Genetic Variation [3]
Neovascular age-related macular degeneration DIS5S9R7 Strong Genetic Variation [1]
46,XY sex reversal 2 DIS0USUN Limited Biomarker [4]
Charcot-Marie-Tooth disease type 3 DIS6DQK1 Limited Biomarker [4]
Colitis DISAF7DD Limited Biomarker [4]
Inflammatory bowel disease DISGN23E Limited Biomarker [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
13 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [5]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [6]
Zoledronate DMIXC7G Approved Zoledronate increases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [7]
Demecolcine DMCZQGK Approved Demecolcine increases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [8]
Azathioprine DMMZSXQ Approved Azathioprine decreases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [9]
Piroxicam DMTK234 Approved Piroxicam decreases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [9]
Rifampicin DM5DSFZ Approved Rifampicin decreases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [10]
Prednisolone DMQ8FR2 Approved Prednisolone decreases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [9]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [11]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [12]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [13]
Formaldehyde DM7Q6M0 Investigative Formaldehyde increases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [8]
Sulforaphane DMQY3L0 Investigative Sulforaphane increases the expression of Paired immunoglobulin-like type 2 receptor alpha (PILRA). [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Drug(s)

References

1 A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants.Nat Genet. 2016 Feb;48(2):134-43. doi: 10.1038/ng.3448. Epub 2015 Dec 21.
2 Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.Nat Genet. 2019 Mar;51(3):404-413. doi: 10.1038/s41588-018-0311-9. Epub 2019 Jan 7.
3 Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer's disease.PLoS Genet. 2018 Nov 2;14(11):e1007427. doi: 10.1371/journal.pgen.1007427. eCollection 2018 Nov.
4 Negative regulation of DSS-induced experimental colitis by PILR.Int Immunol. 2015 Jun;27(6):307-14. doi: 10.1093/intimm/dxv004. Epub 2015 Feb 20.
5 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
6 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
7 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
8 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
9 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
10 Integrated analysis of rifampicin-induced microRNA and gene expression changes in human hepatocytes. Drug Metab Pharmacokinet. 2014;29(4):333-40.
11 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
12 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
13 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
14 Sulforaphane-induced apoptosis in human leukemia HL-60 cells through extrinsic and intrinsic signal pathways and altering associated genes expression assayed by cDNA microarray. Environ Toxicol. 2017 Jan;32(1):311-328.